Evidence map›Paper›PMID 31516460›Full record

ArticleTobacco induced diseases2018

Characterising smokers of menthol and flavoured cigarettes, their attitudes towards tobacco regulation, and the anticipated impact of the Tobacco Products Directive on their smoking and quitting behaviours: The EUREST-PLUS ITC Europe Surveys.

Mateusz Zatoński, Aleksandra Herbeć, Witold Zatoński, Krzysztof Przewoźniak, Kinga Janik-Koncewicz, Ute Mons, Geoffrey T Fong, Tibor Demjén, Yannis Tountas, Antigona C Trofor and 8 more

Open access · goldAbstract read
In one paragraph

Article in Tobacco induced diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. The Impact of Menthol Cigarette Bans: A Systematic Review and Meta-Analysis.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Roll-Your-Own Tobacco Use Among People Smoking Menthol Cigarettes in Great Britain, 2020-2023: A Population-Based Survey.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Use of Menthol Cigarettes and Accessories Among Youth Who Smoked After the Menthol Cigarette Ban in England and Canada, 2021: Implications for Health Equity.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
  11. Responses to Real-World and Hypothetical Menthol Flavor Bans Among US Young Adults Who Smoke Menthol Cigarettes.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The Flavor Train: The Nature and Extent of Flavored Cigarettes in Low- and Middle-Income Countries.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 13 institutions in 10 countries.

Mateusz ZatońskiHealth Promotion Foundation (HPF), Warsaw, Poland.
Aleksandra HerbećHealth Promotion Foundation (HPF), Warsaw, Poland.
Witold ZatońskiHealth Promotion Foundation (HPF), Warsaw, Poland.
Krzysztof PrzewoźniakHealth Promotion Foundation (HPF), Warsaw, Poland.
Kinga Janik-KoncewiczHealth Promotion Foundation (HPF), Warsaw, Poland.
Ute MonsCancer Prevention Unit and WHO Collaborating Centre for Tobacco Control, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Geoffrey T FongDepartment of Psychology & School of Public Health and Health Systems, University of Waterloo (UW), Waterloo, Canada.
Tibor DemjénSmoking or Health Hungarian Foundation (SHHF), Budapest, Hungary.
Yannis TountasUniversity of Athens (UoA), Athens, Greece.
Antigona C TroforUniversity of Medicine and Pharmacy 'Grigore T. Popa' Iasi, Iasi, Romania.
Esteve FernándezTobacco Control Unit, Catalan Institute of Oncology (ICO), and Cancer Control and Prevention Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Catalonia, Spain.
Ann McNeilTobacco Control Unit, Catalan Institute of Oncology (ICO), and Cancer Control and Prevention Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Catalonia, Spain.
Marc WillemsenDepartment of Health Promotion, Maastricht University, Maastricht, the Netherlands.
Karin HummelDepartment of Health Promotion, Maastricht University, Maastricht, the Netherlands.
Anne C K QuahDepartment of Psychology, University of Waterloo (UW), Waterloo, Canada.
Christina N KyriakosEuropean Network for Smoking and Tobacco Prevention (ENSP), Brussels, Belgium.
Constantine I VardavasEuropean Network for Smoking and Tobacco Prevention (ENSP), Brussels, Belgium.
EUREST-PLUS consortium
Maastricht University · NLUniversity of Waterloo · CAEuropean Network for Smoking and Tobacco Prevention · BEGerman Cancer Research Center · DEGrigore T. Popa University of Medicine and Pharmacy · ROHungarian Institute of Occupational Health · HUKing's College London · GBLondon School of Hygiene & Tropical Medicine · GBNational and Kapodistrian University of Athens · GRUK Centre for Tobacco & Alcohol Studies · GBUniversitat de Barcelona · ESUniversity of Crete · GRUniwersytet Kaliski im. Prezydenta Stanisława Wojciechowskiego · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLittle research exists on the sociodemographic characteristics of menthol and flavoured cigarette (MFC) smokers in Europe. This study assessed the proportion of MFC smokers in Europe, their sociodemographic characteristics, and their attitudes towards tobacco control measures.

methodsCross-sectional data were collected in 2016 among 10760 adult current smokers from 8 European countries (ITC Europe Project and EUREST-PLUS). Smokers of menthol, other flavoured, unflavoured tobacco, or no usual brand were compared on sociodemographic characteristics, attitudes towards a range of tobacco control measures (e.g. ban on flavouring), and on intentions regarding their smoking behaviour following the ban on flavoured tobacco. Data were analysed in SPSS Complex Samples Package using univariate analyses.

resultsAmong the respondents, 7.4% smoked menthol cigarettes and 2.9% other flavoured tobacco, but large differences existed between countries (e.g. 0.4% smokers smoked menthol cigarettes in Spain vs 12.4% in England). Compared to other groups, menthol cigarette smokers were younger, more likely to be female, better educated, had higher household income, and smoked fewer cigarettes (all p<0.001). A quarter of menthol smokers supported a ban on additives, compared with almost half of all other smokers (p<0.001). In case of a ban on flavourings, around a fifth of all MFC smokers intended to switch to another brand, and a third to reduce the amount they smoked or to quit smoking, but there was no consistent pattern across MFC smokers among the countries.

conclusionsThe ban on flavourings introduced by the EU Tobacco Products Directive (extended to 2020 for menthols) will affect one in ten smokers in the countries surveyed, which provides an opportunity for targeting these groups with cessation programmes. However, smokers of menthol and flavoured cigarettes in the different European countries are a heterogeneous group and may need different approaches.

Indexed as

ban on additivescross-sectional studyflavoured cigarettesmenthol cigarettes

Identifiers

PMID31516460
PMCPMC6659514
OpenAlexW2905162962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.